Sign in
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide
Journal article   Peer reviewed

Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

Loulia Chatzistamou, Andrew V Schally, Jozsef L Varga, Kate Groot, Patricia Armatis and Ana Maria Bajo
Journal of cancer research and clinical oncology, Vol.127(11), pp.645-652
2001
PMID: 11710593

Abstract

Antineoplastic agents Biological and medical sciences Chemotherapy Medical sciences Pharmacology. Drug treatments

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.164 Endocrinology & Metabolism
1.164.287 Growth Hormone
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details